Latest News - Product Launches and Updates

Tuesday, August 15, 2017 | PracticalDermatology.com, Product Launches and Updates, ISDIN

Isdin Launches Nutraseb™ for Facial Seborrheic Dermatitis

Isdin is rolling out Nutraseb™ Facial Cream, a new steroid-free topical Rx for the multi-symptom management of facial seborrhea and seborrheic dermatitis (SD).  Nutraseb™ is a…

Read the full story

Monday, August 14, 2017 | PracticalDermatology.com, Product Launches and Updates, Revision Skincare

Revision Skincare Launches Nectifirm Advanced

Revision Skincare® is expanding the Nectifirm® collection with Nectifirm® ADVANCED. Nectifirm® ADVANCED harnesses the power of the Microbiome for maintaining skin health.  Acti…

Read the full story

Wednesday, August 09, 2017 | PracticalDermatology.com, Product Launches and Updates, Research and Publications

Bonti’s Novel Gateway Neuromodulator Performs Well in Phase 2A Study

Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profi…

Read the full story

Friday, August 04, 2017 | PracticalDermatology.com, Product Launches and Updates

Serica: New Formulations Target Scars, Stretch Marks with Rain-forest Sourced Ingredients

Serica Moisturizing Scar Formula and Serica Moisturizing Stretch Mark Formula from Cynova Laboratories, formulated with a special blend of ingredients, including Amazonian Pracaxi oil and a patented n…

Read the full story

Friday, July 28, 2017 | PracticalDermatology.com, Product Launches and Updates

Cutanea Life Sciences Unveils Facing Forward Mobile App for Acne Patients

Cutanea Life Sciences, Inc. introduced its Facing Forward mobile application for patients who are prescribed Aktipak (erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicate…

Read the full story

Thursday, July 27, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Atopic Derm, Atopic Dermatitis , Eczema, Psoriasis, Valeant NJ

Valeant’s Newly Minted Ortho Dermatologic Unit Makes Big Splash at Summer AAD

It’s go big or go home for the newly re-branded Valeant Ortho Dermatologic division. At the 2017 American Academy of Dermatology in New York City, the company will officially launch …

Read the full story

Thursday, July 27, 2017 | PracticalDermatology.com, Product Launches and Updates, AbbVie, Boehringer Ingelheim

Boehringer Ingelheim Begins Interchangeability Study Between Adalimumab Biosim and Humira

The first patient has been enrolled into the VOLTAIRE-X interchangeability study, which seeks to demonstrate that BI 695501 is interchangeable with the U.S.-marketed formulation of Humira®* 4…

Read the full story

Thursday, July 27, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Valeant NJ

Valeant Launches Siliq Injection for Psoriasis

 Valeant Pharmaceuticals International, Inc. launched Siliq (brodalumab) Injection during the Summer American Academy of Dermatology (AAD) meeting taking place in New York fro…

Read the full story

Wednesday, July 26, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Research and Publications

Innovation in Action: Meet the DNA Sunscreen that Gets Better the Longer You Wear It

Researchers at Binghamton University, State University of New York have developed a coating made out of DNA that gets better at protecting skin from Ultraviolet light the more you expose it to the sun…

Read the full story

Monday, July 24, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Bristol-Myers Squibb

FDA Expands Approval of Yervoy to Include Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

The FDA has expanded the indication for Bristol-Myers Squibb's Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatr…

Read the full story

Thursday, July 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

FOREO’s New At-Home Blue Light Acne Pen Hits the US and Canada

FOREO's blue-light acne pen is now available in 333 stores in the US and Canada with more to be added by September 2017. The FOREO ESPADA comprises 415 nanometers (nm) of blue light energy comb…

Read the full story

Friday, June 23, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Tattoo

Wontech’s Pico Laser Gets FDA Nod

The U.S. Food and Drug Administration (FDA) cleared WONTECH’s picosecond laser device for tattoo removal. PICOCARE removes tattoos in various colors in less time with 1064nm, 532nm, 595nm, an…

Read the full story

Wednesday, June 21, 2017 | PracticalDermatology.com, Product Launches and Updates

Stratpharma AG’s Wound Care Products Come to the US

Stratpharma’s wound care and scar management portfolio is now available in the US, according to Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company. The portfoli…

Read the full story

Monday, June 12, 2017 | Product Launches and Updates, Research and Publications, Tarix Orphan LLC

EMA Grants Orphan Status to Tarix’s EB Candidiate

The European Medicines Agency (EMA) granted Orphan Drug status to Tarix Orphan LLC’s lead compound, TXA127, for the treatment of epidermolysis bullosa (EB). TXA127 is a pharmaceutical gr…

Read the full story

Tuesday, June 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

FDA Clears Clarify Medical Core Technology for At-home UVB Phototherapy

The US Food and Drug Administration has cleared the Clarify Medical Phototherapy System for marketing, and the new smart, at-home UVB phototherapy system will be available to patients with chronic ski…

Read the full story
Load More